Hypertension and other morbidities with Cushing’s syndrome associated with corticosteroids: a review

References

• PivonelloRde MartinoMCde LeoMLombardiGColaoACushing’s syndromeEndocrinol Metab Clin North Am2008371135149ix18226734
   PubMed Web of Science ®Google Scholar
• ChrousosGPGlucocorticoid therapyFeligPFrohmanLEndocrinology and Metabolism4th edNew YorkMcGraw-Hill Incorporated2001609632
   Google Scholar
• OlumideYMAkinkugbeAOAltraideDComplications of chronic use of skin lightening cosmeticsInt J Dermatol200847434435318377596
   PubMed Web of Science ®Google Scholar
• Castanedo-CazaresJPLopez-LucioRHMoncadaBCushing syndrome following the prescription of antifungal, antibiotic, corticosteroid creamInt J Dermatol200342431812694505
   PubMed Web of Science ®Google Scholar
• WeberSLCushing’s syndrome attributable to topical use of lotrisoneEndocr Pract19973314014415251475
   PubMedGoogle Scholar
• VillanuevaRBBrettEGabriloveJLA cluster of cases of factitious Cushing’s syndromeEndocr Pract20006214314711421530
   PubMedGoogle Scholar
• AziziFJahedAHedayatiMOutbreak of exogenous Cushing’s syndrome due to unlicensed medicationsClin Endocrinol (Oxf)200869692192518462262
   PubMed Web of Science ®Google Scholar
• ErmisBOrsRTastekinAOzkanBCushing’s syndrome secondary to topical corticosteroids abuseClin Endocrinol (Oxf)200358679579612780758
   PubMed Web of Science ®Google Scholar
• LipworthBJSystemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysisArch Intern Med1999159994195510326936
   PubMed Web of Science ®Google Scholar
• PerryRJFindlayCADonaldsonMDCushing’s syndrome, growth impairment, and occult adrenal suppression associated with intranasal steroidsArch Dis Child2002871454812089123
   PubMed Web of Science ®Google Scholar
• KumarSSinghRJReedAMLteifANCushing’s syndrome after intra-articular and intradermal administration of triamcinolone acetonide in three pediatric patientsPediatrics200411361820182415173517
   PubMed Web of Science ®Google Scholar
• LansangMCFarmerTKennedyLDiagnosing the unrecognized systemic absorption of intra-articular and epidural steroid injectionsEndocr Pract200915322522819364690
   PubMed Web of Science ®Google Scholar
• TeelucksinghSBalkaranBGaneshmoorthiAArthurPProlonged childhood Cushing’s syndrome secondary to intralesional triamcinolone acetonideAnn Trop Paediatr2002221899111926057
   PubMed Web of Science ®Google Scholar
• EdmondsLCVanceMLHughesJMMorbidity from paraspinal depo corticosteroid injections for analgesia: Cushing’s syndrome and adrenal suppressionAnesth Analg19917268208222035867
   PubMed Web of Science ®Google Scholar
• LavinPJWorkmanRCushing syndrome induced by serial occipital nerve blocks containing corticosteroidsHeadache200141990290411703480
   PubMed Web of Science ®Google Scholar
• BollandMJBaggWThomasMGLucasJATicehurstRBlackPNCushing’s syndrome due to interaction between inhaled corticosteroids and itraconazoleAnn Pharmacother2004381464914742792
   PubMed Web of Science ®Google Scholar
• GuptaSKDubeMPExogenous Cushing syndrome mimicking human immunodeficiency virus lipodystrophyClin Infect Dis2002356E69E7112203188
   PubMed Web of Science ®Google Scholar
• SarutaTSuzukiHHandaMIgarashiYKondoKSenbaSMultiple factors contribute to the pathogenesis of hypertension in Cushing’s syndromeJ Clin Endocrinol Metab19866222752793510223
   PubMed Web of Science ®Google Scholar
• MagiakouMASmyrnakiPChrousosGPHypertension in Cushing’s syndromeBest Pract Res Clin Endocrinol Metab200620346748216980206
   PubMed Web of Science ®Google Scholar
• RoubertPViossatILonchamptMOEndothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidonJ Vasc Res19933031391448518331
   PubMed Web of Science ®Google Scholar
• KirilovGTomovaADakovskaLKumanovPShinkovAAlexandrovASElevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing’s syndromeEur J Endocrinol2003149654955314640996
   PubMed Web of Science ®Google Scholar
• BorcsokISchairerHUSommerUGlucocorticoids regulate the expression of the human osteoblastic endothelin A receptor geneJ Exp Med19981889156315739802968
   PubMed Web of Science ®Google Scholar
• SmithLSmithJBRegulation of sodium-calcium exchanger by glucocorticoids and growth factors in vascular smooth muscleJ Biol Chem19942694427527275317961668
   PubMed Web of Science ®Google Scholar
• MacefieldVGWilliamsonPMWilsonLRKellyJJGandeviaSCWhitworthJAMuscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humansBlood Press1998742152229858113
   PubMedGoogle Scholar
• KumaiTAsohKTateishiTInvolvement of tyrosine hydroxylase up regulation in dexamethasone-induced hypertension of ratsLife Sci200067161993199911072875
   PubMed Web of Science ®Google Scholar
• WatanabeTNoshiroTAkamaHEffect of dexamethasone on plasma free dopamine: dopaminergic modulation in hypertensive patientsHypertens Res199518Suppl 1S197S1988529061
   PubMedGoogle Scholar
• KennedyBElayanHZieglerMGGlucocorticoid hypertension and nonadrenal phenylethanolamine N-methyltransferaseHypertension19932144154198458643
   PubMed Web of Science ®Google Scholar
• KennedyBZieglerMGCardiac epinephrine synthesis. Regulation by a glucocorticoidCirculation19918428918951860230
   PubMed Web of Science ®Google Scholar
• SakaueMHoffmanBBGlucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cellsJ Clin Invest19918823853891650792
   PubMed Web of Science ®Google Scholar
• HaighRMJonesCTEffect of glucocorticoids on alpha 1-adrenergic receptor binding in rat vascular smooth muscleJ Mol Endocrinol19905141482168709
   PubMed Web of Science ®Google Scholar
• NakamotoHSuzukiHKageyamaYCharacterization of alterations of hemodynamics and neuroendocrine hormones in dexamethasone induced hypertension in dogsClin Exp Hypertens A19911345876061934541
   PubMed Web of Science ®Google Scholar
• EdvinssonLEkbladEHakansonRWahlestedtCNeuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vesselsBr J Pharmacol19848325195256593107
   PubMed Web of Science ®Google Scholar
• IijimaFMalikKUContribution of vasopressin in dexamethasone-induced hypertension in ratsHypertension1988112 Pt 2I42I463346065
   PubMed Web of Science ®Google Scholar
• MurasawaSMatsubaraHKizimaKMaruyamaKMoriYInadaMGlucocorticoids regulate V1a vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cellsHypertension19952646656697558228
   PubMed Web of Science ®Google Scholar
• GardnerDGHaneSTrachewskyDSchenkDBaxterJDAtrial natriuretic peptide mRNA is regulated by glucocorticoids in vivoBiochem Biophys Res Commun19861393104710542945558
   PubMed Web of Science ®Google Scholar
• GarciaRDebinskiWGutkowskaJGluco- and mineralocorticoids may regulate the natriuretic effect and the synthesis and release of atrial natriuretic factor by the rat atria in vivoBiochem Biophys Res Commun198513128068142932106
   PubMed Web of Science ®Google Scholar
• LachanceDGarciaRGutkowskaJCantinMThibaultGMechanisms of release of atrial natriuretic factor. I. Effect of several agonists and steroids on its release by atrial mincesBiochem Biophys Res Commun19861353109010982938580
   PubMed Web of Science ®Google Scholar
• KlettCGantenDHellmannWRegulation of hepatic angiotensinogen synthesis and secretion by steroid hormonesEndocrinology19921306366036681597163
   PubMed Web of Science ®Google Scholar
• PirpirisMSudhirKYeungSJenningsGWhitworthJAPressor responsiveness in corticosteroid-induced hypertension in humansHypertension1992196 Pt 15675741592452
   PubMed Web of Science ®Google Scholar
• SambhiMPWeilMHUdhojiVNPressor responses to norepinephrine in humans before and after corticosteroidsAm J Physiol196220396196313991288
   PubMed Web of Science ®Google Scholar
• LeferAMManwaringJLVerrierRLEffect of corticosteroids on the cardiovascular responses to angiotensin and norepinephrineJ Pharmacol Exp Ther1966154183914288615
   PubMed Web of Science ®Google Scholar
• RussoDFraserRKenyonCJDexamethasone therapy selectively increases the sensitivity to noradrenaline of the rat mesenteric circulationJ Hypertens Suppl198976S126S1272632693
   PubMedGoogle Scholar
• RussoDFraserRKenyonCJIncreased sensitivity to noradrenaline in glucocorticoid-treated rats: the effects of indomethacin and desipramineJ Hypertens1990898278332172372
   PubMed Web of Science ®Google Scholar
• GriendlingKKMinieriCAOllerenshawJDAlexanderRWAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cellsCirc Res1994746114111488187280
   PubMed Web of Science ®Google Scholar
• SternNPalantCOzakiLTuckMLDexamethasone enhances active cation transport in cultured aortic smooth muscle cellsAm J Hypertens1994721461508179849
   PubMed Web of Science ®Google Scholar
• SatoASuzukiHIwaitaYNakazatoYKatoHSarutaTPotentiation of inositol trisphosphate production by dexamethasoneHypertension19921911091151730435
   PubMed Web of Science ®Google Scholar
• SatoASuzukiHNakazatoYShibataHInagamiTSarutaTIncreased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertensionJ Hypertens19941255115167930550
   PubMed Web of Science ®Google Scholar
• GrunfeldJPEloyLMouraAMGanevalDRamos-FrendoBWorcelMEffects of antiglucocorticoids on glucocorticoid hypertension in the ratHypertension1985722922993980072
   PubMed Web of Science ®Google Scholar
• WilliamsonPMKellyJJWhitworthJADose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humansJ Hypertens Suppl1996145S37S419120683
   PubMedGoogle Scholar
• RebuffatAGTamSNawrockiARThe 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonistMol Cell Endocrinol20042141–2273715062542
   PubMed Web of Science ®Google Scholar
• WallerathTWitteKSchaferSCDown-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertensionProc Natl Acad Sci U S A19999623133571336210557325
   PubMed Web of Science ®Google Scholar
• SimmonsWWUngureanu-LongroisDSmithGKSmithTWKellyRAGlucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transportJ Biol Chem19962713923928239378798625
   PubMed Web of Science ®Google Scholar
• LiMFraserTWangJWhitworthJADexamethasone-induced hypertension in the rat: effects of L-arginineClin Exp Pharmacol Physiol1997249–107307329315378
   PubMed Web of Science ®Google Scholar
• PacherPBeckmanJSLiaudetLNitric oxide and peroxynitrite in health and diseasePhysiol Rev200787131542417237348
   PubMed Web of Science ®Google Scholar
• IuchiTAkaikeMMitsuiTGlucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunctionCirc Res2003921818712522124
   PubMed Web of Science ®Google Scholar
• ZhangYHuLMoriTABardenACroftKDWhitworthJAArachidonic acid metabolism in glucocorticoid-induced hypertensionClin Exp Pharmacol Physiol2008355–655756218067589
   PubMed Web of Science ®Google Scholar
• FalardeauPMartineauAProstaglandin I2 and glucocorticoid-induced rise in arterial pressure in the ratJ Hypertens1989786256322509553
   PubMed Web of Science ®Google Scholar
• NasjlettiAErmanACagenLMBaerPGPlasma concentrations, renal excretion, and tissue release of prostaglandins in the rat with dexamethasone-induced hypertensionEndocrinology19841143103310406421564
   PubMed Web of Science ®Google Scholar
• GardinerSMKempPAMarchJEBennettTEffects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious ratsBr J Pharmacol199611811411498733587
   PubMed Web of Science ®Google Scholar
• SiegalTSotiFBiegonAPopEBrewsterMEEffect of a chemical delivery system for dexamethasone (Dex-CDS) on peritumoral edema in an experimental brain tumor modelPharm Res19971456726759165542
   PubMed Web of Science ®Google Scholar
• BirminghamMKSarMStumpfWEDexamethasone target sites in the central nervous system and their potential relevance to mental illnessCell Mol Neurobiol19931343733868252608
   PubMed Web of Science ®Google Scholar
• WangLLOuCCChanJYReceptor-independent activation of GABAergic neurotransmission and receptor-dependent nontranscriptional activation of phosphatidylinositol 3-kinase/protein kinase Akt pathway in short-term cardiovascular actions of dexamethasone at the nucleus tractus solitarii of the ratMol Pharmacol200567248949815523051
   PubMed Web of Science ®Google Scholar
• GravesLLukertBPGlucocorticoid-induced osteoporosis: a clinician’s perspectiveClin Rev Bone Miner Metab2004227990
   Google Scholar
• ShakerJLLukertBPOsteoporosis associated with excess glucocorticoidsEndocrinol Metab Clin North Am2005342341356viiiix15850846
   PubMed Web of Science ®Google Scholar
• AdinoffADHollisterJRSteroid-induced fractures and bone loss in patients with asthmaN Engl J Med198330952652686866051
   PubMed Web of Science ®Google Scholar
• Van StaaTPLeufkensHGAbenhaimLZhangBCooperCUse of oral corticosteroids and risk of fracturesJ Bone Miner Res2000156993100010841167
   PubMed Web of Science ®Google Scholar
• KanisJAJohanssonHOdenAA meta-analysis of prior corticosteroid use and fracture riskJ Bone Miner Res200419689389915125788
   PubMed Web of Science ®Google Scholar
• WongCAWalshLJSmithCJPInhaled corticosteroid use and bone-mineral density in patients with asthmaLancet200035592131399140310791523
   PubMed Web of Science ®Google Scholar
• Van StaaTPLeufkensHGCooperCUse of inhaled corticosteroids and risk of fracturesJ Bone Miner Res200116358158811277277
   PubMed Web of Science ®Google Scholar
• CooperMSRabbittEHGoddardPEBartlettWAHewisonMStewartPMOsteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposureJ Bone Miner Res200217697998612054173
   PubMed Web of Science ®Google Scholar
• WeinsteinRSJilkaRLParfittAMManolagasSCInhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on boneJ Clin Invest199810222742829664068
   PubMed Web of Science ®Google Scholar
• OdellWDTestosterone treatment of men treated with glucocorticoids (editorial)Arch Intern Med199615611113311348639006
   PubMedGoogle Scholar
• La BroccaATerzoloMPiaAPaccottiPde GiuliPAngeliARecurrent thromboembolism as a hallmark of Cushing’s syndromeJ Endocrinol Invest19972042112149211128
   PubMed Web of Science ®Google Scholar
• EremCNuhogluIYilmazMBlood coagulation and fibrinolysis in patients with Cushing’s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levelsJ Endocrinol Invest200932216917419411818
   PubMed Web of Science ®Google Scholar
• PatrassiGMDal Bo ZanonRBoscaroMMartinelliSGirolamiAFurther studies on the hypercoagulable state of patients with Cushing’s syndromeThromb Haemost19855425185204082087
   PubMed Web of Science ®Google Scholar
• OikarinenAHoythyaMJarvinenMDexamethasone-induced plasminogen activator inhibitor: characterization, purification, and preparation of monoclonal antibodiesArch Dermatol Res199028231531582142402
   PubMed Web of Science ®Google Scholar
• Barouski-MillerPAGelehrterTDParadoxical effects of glucocorticoids on regulation of plasminogen activator activity of rat hepatoma cellsPNAS1982797231923226179095
   PubMed Web of Science ®Google Scholar
• BrotmanDJGirodJPPoschAEffects of short-term glucocorticoids on hemostatic factors in healthy volunteersThromb Res2006118224725216005496
   PubMed Web of Science ®Google Scholar
• HasselgrenPOGlucocorticooids and muscle catabolismCurr Opin Clin Nutr Metab Care19992320120510456248
   PubMedGoogle Scholar
• WilliamsTJO’HehirRECzarnyDHorneMBowesGAcute myopathy in severe acute asthma treated with intravenously administered corticosteroidsAm Rev Respir Dis198813724604633341634
   PubMed Web of Science ®Google Scholar
• Van MarleWWoodsKLAcute hydrocortisone myopathyBr Med J198028162352712727427239
   PubMed Web of Science ®Google Scholar
• LarssonHAhrenBInsulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivityDiabetologia199942893694310491753
   PubMed Web of Science ®Google Scholar
• HenriksenJEAlfordFWardGMBeck-NielsenHRisk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patientsDiabetologia19974012143914489447952
   PubMed Web of Science ®Google Scholar
• RizzaRAMandarinoLJGerichJECortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin actionJ Clin Endocrinol Metab19825411311387033265
   PubMed Web of Science ®Google Scholar
• HenriksenJEAlfordFVaagAHandbergABeck-NielsenHIntracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patientsMetabolism19994891128113510484052
   PubMed Web of Science ®Google Scholar
• EkstrandASchalin-JanttiCLofmanMThe effect of (steroid) immunosuppression on skeletal muscle glycogen metabolism in patients after kidney transplantationTransplantation19966168898938623155
   PubMed Web of Science ®Google Scholar
• SchakmanOGilsonHThissenJPMechanisms of glucocorticoid-induced myopathyJ Endocrinol2008197111018372227
   PubMed Web of Science ®Google Scholar
• KrebsMKrssakMBernroiderEMechanism of amino acid-induced skeletal muscle insulin resistance in humansDiabetes200251359960511872656
   PubMed Web of Science ®Google Scholar
• DinneenSAlzaidAMilesJRizzaREffects of the normal nocturnal rise in cortisol on carbohydrate and fat metabolism in IDDMAm J Physiol19952684 Pt 1E595E6037733257
   PubMed Web of Science ®Google Scholar
• TaskinenMRNikkilaEAPelkonenRSaneTPlasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing’s syndromeJ Clin Endocrinol Metab19835736196266348067
   PubMed Web of Science ®Google Scholar
• WajchenbergBLSubcutaneous and visceral adipose tissue: their relation to the metabolic syndromeEndocr Rev200021669773811133069
   PubMed Web of Science ®Google Scholar
• ParekhSAnaniaFAAbnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver diseaseGastroenterology200713262191220717498512
   PubMed Web of Science ®Google Scholar
• NielsenMFCaumoAChandramouliVImpaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjectsAm J Physiol Endocrinol Metab20042861E102E11012965873
   PubMed Web of Science ®Google Scholar
• RooneyDPNeelyRDCullenCThe effect of cortisol on glucose/glucose-6-phosphate cycle activity and insulin actionJ Clin Endocrinol Metab1993775118011838077310
   PubMed Web of Science ®Google Scholar
• MortonNMSecklJR11beta-hydroxysteroid dehydrogenase type 1 and obesityFront Horm Res20083614616418230901
   PubMed Web of Science ®Google Scholar
• FasshauerMPaschkeRRegulation of adipocytokines and insulin resistanceDiabetologia200346121594160314605806
   PubMed Web of Science ®Google Scholar
• BeardJCHalterJBBestJDPfeiferMAPorteDJrDexamethasone-induced insulin resistance enhances B cell responsiveness to glucose level in normal menAm J Physiol19842475 Pt 1E592E5966388353
   PubMed Web of Science ®Google Scholar
• GrillVPigonJHartlingSGBinderCEfendicSEffects of dexamethasone on glucose-induced insulin and proinsulin release in low and high insulin respondersMetabolism19903932512582407926
   PubMed Web of Science ®Google Scholar
• MatsumotoKYamasakiHAkazawaSHigh-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic beta-cells in normal menJ Clin Endocrinol Metab1996817262126268675587
   PubMed Web of Science ®Google Scholar
• BesseCNicodNTappyLChanges in insulin secretion and glucose metabolism induced by dexamethasone in lean and obese femalesObes Res200513230631115800288
   PubMedGoogle Scholar
• ManciniTKolaBManteroFBoscaroMArnaldiGHigh cardiovascular risk in patients with Cushing’s syndrome according to 1999 WHO/ISH guidelinesClin Endocrinol (Oxf)200461676877715579193
   PubMed Web of Science ®Google Scholar
• WeiLMacDonaldTMWalkerBRTaking glucocorticoids by prescription is associated with subsequent cardiovascular diseaseAnn Intern Med20041411076477015545676
   PubMed Web of Science ®Google Scholar
• SouvereinPCBerardAvan StaaTPUse of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control studyHeart200490885986515253953
   PubMed Web of Science ®Google Scholar
• HoleDJWattGCDavey-SmithGHartCLGillisCRHawthorneVMImpaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ199631370597117158819439
   PubMed Web of Science ®Google Scholar
• DeMariaANRelative risk of cardiovascular events in patients with rheumatoid arthritisAm J Cardiol.2002896A33D38D
   Web of Science ®Google Scholar
• UddhammarAErikssonALNystromLStenlingRRantapaa-DahlqvistSIncreased mortality due to cardiovascular disease in patients with giant cell arteritis in northern SwedenJ Rheumatol200229473774211950015
   PubMed Web of Science ®Google Scholar
• NashelDJIs atherosclerosis a complication of long-term corticosteroid treatment?Am J Med19868059259293518440
   PubMed Web of Science ®Google Scholar
• MaxwellSRMootsRJKendallMJCorticosteroids: do they damage the cardiovascular system?Postgrad Med J1994708308638707870631
   PubMed Web of Science ®Google Scholar
• BertramCEHansonMAPrenatal programming of postnatal endocrine responses by glucocorticoidsReproduction2002124445946712361463
   PubMed Web of Science ®Google Scholar
• KayHHBirdIMCoeCLDudleyDJAntenatal steroid treatment and adverse fetal effects: what is the evidence?J Soc Gynecol Investig200075269278
   Google Scholar
• NewnhamJPIs prenatal glucocorticoid administration another origin of adult disease?Clin Exp Pharmacol Physiol2001281195796111703405
   PubMed Web of Science ®Google Scholar
• Langley-EvansSCShermanRCWelhamSJNwagwuMOGardnerDSJacksonAAIntrauterine programming of hypertension: the role of the renin-angiotensin systemBiochem Soc Trans1999272889310093713
   PubMed Web of Science ®Google Scholar
• BenediktssonRLindsayRNobleJSecklJREdwardsCRGlucocorticoid exposure in utero: new model for adult hypertensionLancet199334188413393418094115
   PubMed Web of Science ®Google Scholar
• ConnellJMWhitworthJADaviesDLLeverAFRichardsAMFraserREffects of ACTH and cortisol administration on blood pressure, electrolyte metabolism, atrial natriuretic peptide and renal function in normal manJ Hypertens1987544254332822795
   PubMed Web of Science ®Google Scholar
• KellyJJTamSHWilliamsonPMLawsonJWhitworthJAThe nitric oxide system and cortisol-induced hypertension in humansClin Exp Pharmacol Physiol199825119459469807669
   PubMed Web of Science ®Google Scholar
• TurnerSWWenCLiMFraserTBWhitworthJAAdrenocorticotrophin dose-response relationships in the rat: haemodynamic, metabolic and hormonal effectsJ Hypertens19981655936009797170
   PubMed Web of Science ®Google Scholar
• WhitworthJAAdrenocorticotrophin and steroid-induced hypertension in humansKidney Int Suppl199237S34S371321309
   PubMedGoogle Scholar
• MillsEHCoghlanJPDentonDASpenceCDWhitworthJAScogginsBAThe effect of sodium depletion and potassium loading on cortisol induced hypertension in sheepActa Endocrinol (Copenh)198611322983043776438
   PubMedGoogle Scholar
• WhitworthJASainesDScogginsBAPotentiation of ACTH hypertension in man with salt loadingClin Exp Pharmacol Physiol19851232392432992854
   PubMed Web of Science ®Google Scholar
• HumphreyTJFanJSCoghlanJPInter-relationships between sodium and potassium intake and the blood pressure effects of ACTH in sheepJ Hypertens19831119266099379
   PubMedGoogle Scholar
• HuLZhangYLimPSApocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the ratAm J Hypertens200619441341816580579
   PubMed Web of Science ®Google Scholar
• MondoCKZhangYde Macedo PossamaiVN-acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the ratClin Exp Hypertens2006282738416546835
   PubMed Web of Science ®Google Scholar
• ZhangYChanMMAndrewsMCApocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the ratAm J Hypertens200518791091616053986
   PubMed Web of Science ®Google Scholar
• WenCLiMFraserTWangJTurnerSWWhitworthJAL-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the ratBlood Press20009529830411193135
   PubMed Web of Science ®Google Scholar
• ZhangYMiaoYWhitworthJAAspirin prevents and partially reverses adrenocorticotropic hormone-induced hypertension in the ratAm J Hypertens200720111222122817954371
   PubMed Web of Science ®Google Scholar
• LiMWenCMartinAWhitworthJADehydroepiandrosterone does not prevent adrenocorticotrophin-induced hypertension in conscious ratsClin Exp Pharmacol Physiol19962354354378713685
   PubMed Web of Science ®Google Scholar